Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Masatoshi Nakamachi"'
Publikováno v:
The Showa University Journal of Medical Sciences. 12:211-217
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f38f28a882bad4d698d76af9fbbfc212
https://doi.org/10.15369/sujms1989.12.211
https://doi.org/10.15369/sujms1989.12.211
Autor:
Masaaki Matsukawa, Wataru Yamamoto, Shinichirou Okabe, Mototsugu Fujimori, Masatoshi Nakamachi, Takahiko Kouda, Takeshi Yamasaki, Minoru Kurihara, Atsushi Satoh, Ken Shimada, Kenya Tadokoro
Publikováno v:
The Showa University Journal of Medical Sciences. 12:253-258
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab90284ecc0ecccefe13554df2334cd5
https://doi.org/10.15369/sujms1989.12.253
https://doi.org/10.15369/sujms1989.12.253
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 37(7)
5-fluorouracil (5-FU) has been the mainstay of systemic therapy since its initial development 50 years ago for gastrointestinal cancer. In Japan, the development of orally administered fluoropyrimidines that maintain or improve the effectiveness of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::801c1d1baa1ae28ff30ea3a4cd524bb3
https://pubmed.ncbi.nlm.nih.gov/20647697
https://pubmed.ncbi.nlm.nih.gov/20647697
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(8)
According to the Japanese Colorectal Cancer Treatment Guideline by the Japanese Society for Cancer of the Colon and Rectum, the recommendation for recurrent colorectal cancer consists of 2 options according to the number of metastatic organs and surg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::23d4649dace8c7ab1624ff5030cb50f5
https://pubmed.ncbi.nlm.nih.gov/19692761
https://pubmed.ncbi.nlm.nih.gov/19692761
Autor:
Atsushi, Sato, Masatoshi, Nakamachi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(2)
The prognostic significance of histologic type is unclear in patients with gastric cancer. However, the regimen has been actually selected by histologic type from clinical reports and clinical experiences. The differentiated type is related to metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6820f0193ce5d8c1eb0a1125e56a2f9b
https://pubmed.ncbi.nlm.nih.gov/19223732
https://pubmed.ncbi.nlm.nih.gov/19223732
Autor:
Atsushi, Sato, Masatoshi, Nakamachi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 35(9)
The ACTS-GC trial suggested that adjuvant chemotherapy with S-1 should be adopted as the standard treatment for stage II/III gastric cancer after curative D2 gastric dissection. In the JCOG9912 trial (5-FU vs CPT-11+CDDP (CP), 5-FU and vs S-1), the M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e8a471f4ef7be66aaa429eafb4f24d0
https://pubmed.ncbi.nlm.nih.gov/18799898
https://pubmed.ncbi.nlm.nih.gov/18799898
Autor:
Satoshi, Morita, Kojiro, Shimozuma, Atsushi, Sato, Masatoshi, Nakamachi, Jane, Blazeby, Karen, West, Shunichi, Fukuhara, Junichi, Sakamoto
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 31(8)
The pilot testing of the Japanese translation of the European Organization for Research and Treatment of Cancer (EORTC) gastric cancer module (QLQ-STO22) was done for 10 patients (6 men; 4 women) with gastric cancer. Age ranged from 23 to 73. Five pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fad57a5d4b2f6c92a60235961607df52
https://pubmed.ncbi.nlm.nih.gov/15332542
https://pubmed.ncbi.nlm.nih.gov/15332542
Autor:
Masatoshi Nakamachi, Wataru Yamamoto, Minoru Kurihara, Atsushi Sato, Jun Ushio, Ken Shimada, Masaaki Matsukawa
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 5(4)
A 58-year-old man was diagnosed as having type 3 gastric cancer (poorly differentiated adenocarcinoma). He underwent total gastrectomy with splenectomy, as well as D3 dissection, and received postoperative chemotherapy combining oral uracil and futra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27a4590d044046e7a802ac45dd640543
https://pubmed.ncbi.nlm.nih.gov/12491082
https://pubmed.ncbi.nlm.nih.gov/12491082
Autor:
Atsushi, Satou, Tamaki, Yamazaki, Naotaka, Nukariya, Masatoshi, Nakamachi, Ken, Shimada, Masaaki, Matsukawa, Minoru, Kurihara
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 29(2)
Nausea and vomiting induced by chemotherapy have an impact on cancer patients' quality of life (QOL). The Functional Living Index-Emesis (FLIE), which is designed to assess the change in QOL from the influence of nausea and vomiting is rarely used in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e360103f36910898144a22f1169b95f8
https://pubmed.ncbi.nlm.nih.gov/11865635
https://pubmed.ncbi.nlm.nih.gov/11865635
Autor:
Atsushi Sato, Takeshi Yamazaki, Takahiko Koda, Ken Shimada, Masaaki Matsukawa, Minoru Kurihara, Masatoshi Nakamachi
Publikováno v:
Cancer chemotherapy and pharmacology. 47(5)
Purpose: Irinotecan hydrochloride shows a strong activity against gastric cancer and colorectal cancer, while combined therapy with irinotecan and cisplatin is useful for gastric cancer. However, myelosuppression and diarrhea are still dose-limiting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef718bcc7c228847f201654950c1610
https://pubmed.ncbi.nlm.nih.gov/11391851
https://pubmed.ncbi.nlm.nih.gov/11391851